The Centers for Disease Control and Prevention (CDC) awarded a single-award Indefinite Delivery Contract (IDC) to Srisai Biopharmaceutical Solutions LLC, a self-certified small disadvantaged business, to provide comprehensive biospecimen storage services in support of the National Health and Nutrition Examination Survey (NHANES) program. The $2,591,214.34 IDC, set aside for small businesses, has a period of performance through March 2030 and will likely involve continued storage of approximately 500,000 NHANES biospecimens at Srisai's facility in Maryland.
The original solicitation sought a contractor to receive, store, maintain, and ship NHANES biological samples, primarily 2ml Nunc Cryo vials, while also providing freezer maintenance, inventory control, sample management, and disposal services. Proposals were evaluated based on technical approach, staffing, facilities, and past performance, with the contract awarded as a Firm Fixed Price IDIQ with a one-year base period and four one-year option periods. The place of performance will be at the contractor's facility in Hyattsville, Maryland.